Kitayama Mitchell W 4
4 · Astrana Health, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Astrana Health (ASTH) Director Mitchell Kitayama Receives Award
What Happened
- Mitchell W. Kitayama, a director of Astrana Health, Inc. (ASTH), received a grant of 4,991 restricted shares on June 10, 2026. The Form 4 reports an acquisition price of $0.00 for the award (i.e., a compensatory grant rather than a market purchase).
Key Details
- Transaction date: June 10, 2026; filing date: June 12, 2026 (filed within the typical 2-business‑day Form 4 window).
- Transaction type/code: Award/Grant (A).
- Shares acquired: 4,991 restricted shares; reported acquisition amount: $0.00.
- Vesting: Per footnotes, shares vest on the earlier of (i) June 10, 2027 or (ii) the date of Astrana Health’s 2027 annual meeting; grant made under the Issuer’s 2024 Equity Incentive Plan.
- Shares owned after transaction: Not specified in the information provided.
- No 10b5-1 plan, tax‑withholding sale, or cashless exercise noted in the filing excerpts provided.
Context
- This is a typical director compensation award (restricted stock) rather than an open‑market purchase or sale. Restricted shares are subject to vesting and are not immediately liquid, so the grant signals compensation/retention rather than an immediate insider market view.
Insider Transaction Report
Form 4
Kitayama Mitchell W
Director
Transactions
- Award
Common Stock
[F1][F2]2026-06-10+4,991→ 32,837 total
Footnotes (2)
- [F1]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
- [F2]Includes 4,991 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Signature
/s/ Kathy Diep, as Attorney-in-Fact|2026-06-12